|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 2型糖尿病患者采用血管紧张素转换酶抑制剂治疗后血清肌酐急性升高及其继续治疗对主要临床结局的影响显示文摘血管紧张素转换酶抑制剂开始治疗后血清肌酐急性升高≥30%时推荐停药。但血清肌酐升高后继续服药或停药对主要临床结局的长期影响仍不明确。在ADVANCE(糖尿病与血管疾病行动:培哚普利-吲达帕胺与达美康缓释片对照评估)试验中,11 140例糖尿病患者在6周活性导入期后随机采用培哚普利-吲达帕胺或安慰剂治疗。 | Ohkuma T Jun M Rodgers A Cooper ME Glasziou P Hamet P Harrap S Mancia G Marre M Neal B Perkovic V Poulter N Williams B Zoungas S Chalmers J Woodward M 赵狄 练桂丽 | 2019 | 中华高血压杂志2019，27，1： | 6 |
| 2 | 脂质组学改善传统危险因素预测的2型糖尿病患者的心血管事件显示文摘临床脂质测定并未显示出糖尿病或心血管病相关的脂质代谢改变的复杂性。脂质组学则能够评估可作为疾病风险潜在标志物的数百种脂质种类。方法:纳入来自糖尿病治疗和血管保护行动。 | 刘莉 叶鹏 Alshehry ZH Mundra PA Barlow CK Mellett NA Wong G McConville MJ Simes J Tonkin AM Sullivan DR Barnes EH Nestel PJ Kingwell BA Marre M Neal B Poulter NR Rodgers A Williams B Zoungas S Hillis GS Chalmers J Woodward M Meikle PJ | 2016 | 中华高血压杂志2016，24，10： | 3 |
| 3 | 糖尿病患者累积收缩压负荷与心血管病风险的关系显示文摘该研究旨在评估2型糖尿病患者累积收缩压负荷与心血管事件风险的关系。方法:对百普乐和达美康缓释片对糖尿病和血管疾病的对照评估试验的观察性研究(action in diabetes and vascular disease preterax and diamicron MR controlled evaluation post trial observational study, ADVANCE-ON)中的2型糖尿病患者进行事后分析。 | Wang N Harris K Hamet P Harrap S Mancia G Poulter N Williams B Zoungas S Woodward M Chalmers J Rodgers A 刘青(译) 郑武洪(审校) | 2022 | 中华高血压杂志2022，30，12： | 2 |
| 4 | The anglo-scandinavian cardiac outcomes trial lipid lowering arm: extended observations 2 years after trial closure显示文摘 | Sever PS Poulter NR Dahlof B | 2008 | Eur Heart J2008，29，4： | 1 |
| 5 | Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations,in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm(ASCOT-LLA):a multi centre randomised controlled trial显示文摘 | Sever PS Dahl(o)f B Poulter N | 2003 | Lancet2003，361，9364： | 1 |
| 6 | A recombination hot sport in the Rh genes revealed by analysis of unrelated donors with the rare Dphenotype显示文摘 | Kemp T J Poulter M Carritt B | 1996 | Am J Hum Genet1996，59，5： | 1 |
| 7 | Guidelines for management of hypertension:report of the fourth working party of the British Hypertension Society,2004-BHSO显示文摘 | Williams B Poulter NR Brown MJ | 2004 | J Hum Hypertens2004，18，3： | 1 |
| 8 | Prevention of coronary and stroke events with atorvastatin in hepertensive patients who have aver- age or lower-than-average cholesterol concentrations, in the Anglo- Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT- LLA) :a multicentre randomized controlled trial 显示文摘 | Sever PS Dahlof B Poulter NR | 2003 | Lancet2003，361，9364： | 1 |
| 9 | Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA)显示文摘 | Poulter NR Wedel H Dahlof B | 2005 | Lancet2005，366，： | 1 |
| 10 | Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations,in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA):a multicentre randomised controlled trial显示文摘 | Sever PS Dahlf B Poulter NR | 2004 | Drugs2004，64，2： | 1 |
| 11 | Pre- stroke events with ator- vastatin in hypertensive patients who have aver-age or lower-than-average cholesterol comcentra- tions, in the anglo-scandinavian cardiac outcomes trial-ipid lowering arm (ASCOT-LLA): a multicen- tre randomised controlled trial显示文摘 | SEVER P S DAHLOF B vention of coronary and POULTER N R | 2003 | Lancet2003，361，9364： | 1 |
| 12 | Conservation - driven propagation of an epiphytic orchid ( Epidendrum nocturnum ) with a mycorrhizal funguS显示文摘 | Lawrence W Z Poulter S B Mcdonald K I | 2007 | Hort Science2007，42，1： | 1 |
| 13 | Performance of the ASSIGN cardiovascular disease risk score on a UK cohort of patients from general practice 显示文摘 | de la Iglesia B Potter JF Poulter NR | 2011 | Heart2011，97，6： | 1 |
| 14 | Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations,in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm(ASCOT-LLA):a multicenter randomised controlled trial显示文摘 | Sever PS Dahlof B Poulter NR | 2003 | Lancet2003，361，： | 1 |
| 15 | British hypertension society guidelines for hypertension management 2004 (BFS-Ⅳ): summary 显示文摘 | Williams B Poulter NR Brown MJ Davis M McInnes GT Potter JF Sever PS Thom SM BHS guidelines working party for the British Hypertension Society | 2004 | BMJ2004，328，2351： | 1 |
| 16 | Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (AS-COT-BPLA)显示文摘 | Poulter NR Wedel H Dahlof B | | 0，，9489： | 1 |
| 17 | Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA) : a multicentre ran- domized controlledtrial显示文摘 | SEVER P S DAHLOF B POULTER N R | 2003 | Lancet2003，361，9364： | 1 |
| 18 | Prevention ofcoronary andstroke events with atorvastatin in hypertensive patients who haveaverage or lower than average cholesterolconcentrations显示文摘 | SEVER P S DAHLOF B POULTER N R | 2015 | Lancet2015，361，9364： | 1 |
| 19 | Novel peptide fragments originating from PGLa and the caerulein and xenopsin precursors from Xenopus laevis显示文摘 | GIBSON B W POULTER L WILLIAMS D H | 1986 | J Biol Chem1986，261，12： | 1 |
| 20 | Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower than average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Ttrial-Lipid Lowering Ann (ASCOT-LLA) : a muhicentre randomized controlled trial显示文摘 | SEVER P S DAHLOF B POULTER N R | 2003 | Lancet2003，361，8： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员